This page shows the latest Pfizer/BioNTech news and features for those working in and with pharma, biotech and healthcare.
The Moderna vaccine will be administered in two doses, given between four and 12 weeks apart, in the same way as the Pfizer-BioNTech and Oxford-AstraZeneca vaccines that are already ... The Moderna vaccine can also be shipped at -20C, which is closer to
Pfizer and BioNTech’s mRNA-based COVID-19 vaccine has demonstrated 100% efficacy and safety in adolescents, including children as young as 12 years old. ... Pfizer and BioNTech added that the vaccine was also well tolerated, with side effects
mRNA-based vaccines, such as Pfizer/BioNTech and Moderna’s respective jabs, have higher efficacy rates compared to both CanSinoBIO and J&J’s vaccines, but also require ultra-low storage
German biotech company BioNTech has forecast a significant 9.8bn for sales of its Pfizer-partnered COVID-19 vaccine in 2021. ... added. Pfizer and BioNTech are working on modified versions of their COVID-19 vaccine to address new variants of the
A new study, conducted by researchers from Sheffield and Oxford Universities, has found that a single dose of the Pfizer/BioNTech vaccine induces a ‘robust’ immune response against COVID-19. ... The researchers found that 99% of people generated a
The CHMP has also recommended a new manufacturing site for Pfizer/BioNTech’s vaccine, located in the German city of Marburg. ... Originally, the Pfizer/BioNTech vaccine was required to be stored at a temperature between -90˚C to -60˚C in special
More from news
Approximately 49 fully matching, plus 96 partially matching documents found.
In the UK, the looming Brexit sparked new models of regulatory approval and fast-track opportunities, as recently observed in the rapid approval of Pfizer’s COVID-19 vaccine. ... So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University
Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same. ... A number of top pharma companies are included in the newly
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Both the Oxford/AstraZeneca and Pfizer/BioNTech vaccines were developed using platform technologies which didn’t exist 20 years ago, allowing these vaccines to be developed much faster.
The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so
Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the
At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection. ... At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more
At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...